Literature DB >> 10407221

Effects of anabolic-androgenic steroid use or gonadal testosterone suppression on serum leptin concentration in men.

M S Hislop1, B D Ratanjee, S G Soule, A D Marais.   

Abstract

OBJECTIVE: Serum leptin concentration shows a sexual dimorphism that is not accounted for by gender differences in adiposity. A strong inverse association exists between serum leptin and testosterone concentrations in men, pointing to a likely influence of gonadal sex steroids on serum leptin concentration. The aim of this study was to investigate whether manipulation of sex steroid hormones in men would alter serum leptin concentration independently of changes in fat mass. DESIGN AND METHODS: The effects of sex steroid suppression on serum leptin concentration were investigated in nine healthy men in whom testosterone had been reversibly suppressed for 5 weeks after treatment with intramuscular triptorelin. The effects of sex steroid supplementation were investigated in nine male bodybuilders who self-administered anabolic--androgenic steroids (AAS) for a mean period of 6.5 weeks. A control group received no hormonal treatment.
RESULTS: Testosterone concentration was significantly reduced by triptorelin administration (7.32+/- 1.92ng/ml at baseline compared with 1.15+/-0.57ng/ml at 5 weeks, P=0.002). High-dose AAS use was confirmed by urine analysis. Body fat percentage was unaffected by the AAS or triptorelin intervention (P>0.19). Leptin concentration was significantly reduced after one cycle of AAS use (2.40+/-0. 98ng/ml off cycle compared with 1.63+/-0.37ng/ml on cycle, P=0.012), and was significantly increased by triptorelin administration (2. 96+/-1.50ng/ml at baseline compared with 6.63+/-4.67ng/ml at five weeks, P=0.004). No significant change occurred in the control group.
CONCLUSION: Androgenic sex hormone supplementation decreases serum leptin concentration, whereas suppression increases serum leptin concentration, independently of changes in body fat mass in healthy men. The sexual dimorphism evident in serum leptin concentration is likely to be due to a suppressive effect of testosterone on serum leptin concentration in males.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10407221     DOI: 10.1530/eje.0.1410040

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  6 in total

Review 1.  Effects of androgen replacement on metabolism and physical performances in male hypogonadism.

Authors:  M Zitzmann; E Nieschlag
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

Review 2.  Leptin, reproduction and sex steroids.

Authors:  X Casabiell; V Piñeiro; F Vega; L F De La Cruz; C Diéguez; F F Casanueva
Journal:  Pituitary       Date:  2001 Jan-Apr       Impact factor: 4.107

3.  Preclinical characterization of a (S)-N-(4-cyano-3-trifluoromethyl-phenyl)-3-(3-fluoro, 4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide: a selective androgen receptor modulator for hormonal male contraception.

Authors:  Amanda Jones; Jiyun Chen; Dong Jin Hwang; Duane D Miller; James T Dalton
Journal:  Endocrinology       Date:  2008-09-04       Impact factor: 4.736

4.  Identification of serum biomarkers for aging and anabolic response.

Authors:  Camellia Banerjee; Jagadish Ulloor; Edgar L Dillon; Qusai Dahodwala; Brittani Franklin; Thomas Storer; Paola Sebastiani; Melinda Sheffield-Moore; Randall J Urban; Shalender Bhasin; Monty Montano
Journal:  Immun Ageing       Date:  2011-06-20       Impact factor: 6.400

Review 5.  The integrative role of leptin, oestrogen and the insulin family in obesity-associated breast cancer: potential effects of exercise.

Authors:  S Schmidt; J M Monk; L E Robinson; M Mourtzakis
Journal:  Obes Rev       Date:  2015-04-15       Impact factor: 9.213

6.  Low Plasma Leptin and High Soluble Leptin Receptor Levels Are Associated With Mild Cognitive Impairment in Type 2 Diabetic Patients.

Authors:  Han Yin; Sai Tian; Rong Huang; Rongrong Cai; Dan Guo; Hongyan Lin; Jiaqi Wang; Shaohua Wang
Journal:  Front Aging Neurosci       Date:  2018-05-15       Impact factor: 5.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.